1.
Singh YN, Blumenthal M. Kava an
overview. HerbalGram
1997;39:33-44, 46-55.
2. Norton SA, Ruze
P. Kava dermopathy. J Am Acad
Dermatol 1994;31:89-97.
3. Moulds RF,
Malani J. Kava: herbal panacea or
liver poison? Med J Aust
2003;178:451-3.
4. Lazarou, J,
Pomeranz, BH, Corey, PN,
"Incidence of adverse drug
reactions in hospitalized
patients: a meta-analysis of
prospective studies," Journal of
the American Medical Association
(Chicago, IL: American Medical
Association, 1998),
1998;279:1200-1205
5. Baum SS, Hill
R, Rommelspacher H. Effect of kava
extract and individual kavapyrones
on neurotransmitter levels in the
nucleus accumbens of rats. Prog
Neuropsychopharmacol Biol
Psychiatry 1998;22:1105-1120.
6. Garner LF,
Klinger JD. Some visual effects
caused by the beverage kava. J
Ethnopharmacol 1985;13:307-311.
7. Woelk H,
Kapoula O, Lehrl S, et al.
[Comparison of kava special
extract WS 1490 and
benzodiazepines in patients with
anxiety]. [Article in German]. Z
Allg Med 1993;69:271â€"7.
7. Volz HP, Kieser M. Kava-kava
extract WS 1490 versus placebo in
anxiety disorders--a randomized
placebo-controlled 25-week
outpatient trial.
Pharmacopsychiatry 1997;30:1-5.
8. Lehmann E,
Kinzler E, Friedemann J. Efficacy
of a special Kava extract (Piper
methysticum) in patients with
states of anxiety, tension and
excitedness of non-mental origin-
a double-blind placebo-controlled
study of four weeks treatment.
Phytomedicine 1996;3:113-9.
9. Malsch U,
Kieser M. Efficacy of kava-kava in
the treatment of non-psychotic
anxiety, following pretreatment
with benzodiazepines.
Psychopharmacology (Berl)
2001;157:277-83.
10. Warnecke G.
[Psychosomatic dysfunctions in the
female climacteric. Clinical
effectiveness and tolerance of
Kava extract WS 1490]. [Article in
German]. Fortschr Med
1991;109:119-22.
11. Jussofie A,
Schmiz A, Hiemke C. Kavapyrone
enriched extract from Piper
methysticum as modulator of the
GABA binding site in different
regions of rat brain.
Psychopharmacology
1994;116:469-74.
12. Schelosky L,
Raffaup C, Jendroska K, Poewe W.
Kava and dopamine antagonism. J
Neurol Neurosurg Psychiatry
1995;58:639-40.
13 Seitz U,
Schule A, Gleitz J. [3H]-monoamine
uptake inhibititon properties of
kava pyrones. Planta Med
1997;63:548-549.
14. Cairney S,
Maruff P, Clough AR, et al.
Saccade and cognitive impairment
associated with kava intoxication.
Hum Psychopharmacol
2003;18:525-33.
14. Fetrow CW, Avila JR.
Professional's Handbook of
Complementary & Alternative
Medicines. 1st ed. Springhouse,
PA: Springhouse Corp., 1999.
15. Pierce A. The
American Pharmaceutical
Association Practical Guide to
Natural Medicines. New York: The
Stonesong Press, 1999:19.
16. Pittler MH,
Ernst E. Efficacy of kava extract
for treating anxiety: systematic
review and meta-analysis. J Clin
Psychopharmacol 2000;20:84-9.
17. Escher M,
Desmeules J, Giostra E, Mentha G.
Drug Points: hepatitis associated
with kava, a herbal remedy for
anxiety. BMJ 2001;322:139.
18. Schmidt P,
Boehncke WH. Delayed-type
hypersensitivity reaction to
kava-kava extract. Contact
Dermatitis 2000;42:363-4.
19. Brinker F.
Herb Contraindications and Drug
Interactions. 2nd ed. Sandy, OR:
Eclectic Medical Publications,
1998.
20. Strahl S,
Ehret V, Dahm HH, Maier KP.
[Necrotizing hepatitis after
taking herbal medication].
[Article in German] (abstract).
Dtsch Med Wochenschr
1998;123:1410-4.
21. Bilia AR,
Gallori S, Vincieri FF. Kava-kava
and anxiety: growing knowledge
about the efficacy and safety.
Life Sci 2002;70:2581-97.
Return to
Kava Kava Introduction